Testing effectiveness (Phase 2)Ended earlyNCT03139032
What this trial is testing
Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
Who this might be right for
Inflammatory Bowel DiseasesSkin Extra-intestinal Manifestations
Arena Pharmaceuticals 1